R. Scott Greer, Director at NEKTAR THERAPEUTICS (NKTR), sold 10,000 shares at $67.39 ($674K) on 2018-09-04, disclosed to the SEC on 2018-09-06.
Open-market sale of $674k NKTR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SIEN | BUY | 2018-05-09 | $300K | — | Filing → |
| NKTR | SELL | 2018-04-09 | $2.8M | — | Filing → |
| NKTR | BUY | 2016-10-25 | $203K | — | Filing → |